NASDAQ: PLABPhotronics Inc Stock
$26.09-0.43 (-1.62%)
Updated Apr 18, 2024
PLAB Price
$26.09
Fair Value Price
$28.41
Market Cap
$1.65B
52 Week Low
$13.86
52 Week High
$34.16
P/E
11.6x
P/B
1.62x
P/S
2.06x
PEG
0.53x
Dividend Yield
N/A
Revenue
$897.32M
Earnings
$137.68M
Gross Margin
37.8%
Operating Margin
23.46%
Profit Margin
15.3%
Debt to Equity
0.23
Operating Cash Flow
$316M
Beta
1.36
Next Earnings
May 22, 2024
Ex-Dividend
N/A
Next Dividend
N/A
PLAB Overview
Photronics, Inc., together with its subsidiaries, engages in the manufacture and sale of photomask products and services in the United States, Taiwan, Korea, Europe, China, and internationally. The company offers photomasks that are used in the manufacture of integrated circuits and flat panel displays (FPDs); and to transfer circuit patterns onto semiconductor wafers, FDP substrates, and other types of electrical and optical components. It sells its products to semiconductor and FPD manufacturers, designers, and foundries, as well as to other high-performance electronics manufacturers through its sales personnel and customer service representatives. The company was formerly known as Photronic Labs, Inc. and changed its name to Photronics, Inc. in 1990. Photronics, Inc. was incorporated in 1969 and is based in Brookfield, Connecticut.
Zen Score
–
Industry Average (38)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how PLAB scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
PLAB ($26.09) is undervalued by 8.16% relative to our estimate of its Fair Value price of $28.41 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
PLAB ($26.09) is not significantly undervalued (8.16%) relative to our estimate of its Fair Value price of $28.41 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
PLAB ($26.09) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more PLAB due diligence checks available for Premium users.
Be the first to know about important PLAB news, forecast changes, insider trades & much more!
PLAB News
Valuation
PLAB fair value
Fair Value of PLAB stock based on Discounted Cash Flow (DCF)
Price
$26.09
Fair Value
$28.41
Undervalued by
8.16%
PLAB ($26.09) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
PLAB ($26.09) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
PLAB ($26.09) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
PLAB price to earnings (PE)
For valuing profitable companies with steady earnings
Company
11.6x
Industry
37.88x
Market
41.33x
PLAB is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
PLAB is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
PLAB price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.62x
Industry
11.1x
PLAB is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
PLAB price to earnings growth (PEG)
For valuing profitable companies with growth potential
PLAB is good value based... subscribe to Premium to read more.
PEG Value Valuation
PLAB's financial health
Profit margin
Revenue
$216.3M
Net Income
$26.2M
Profit Margin
12.1%
PLAB's Earnings (EBIT) of $210.53M... subscribe to Premium to read more.
Interest Coverage Financials
PLAB's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.6B
Liabilities
$235.8M
Debt to equity
0.23
PLAB's short-term assets ($807.68M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PLAB's short-term assets ($807.68M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PLAB's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
PLAB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$41.5M
Investing
-$42.2M
Financing
-$2.9M
PLAB's operating cash flow ($316.00M)... subscribe to Premium to read more.
Debt Coverage Financials
PLAB vs Semiconductor Equipment Stocks
Photronics Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.